NHS prepares to introduce life saving COVID-19 vaccine

Watch more of our videos on ShotsTV.com 
and on Freeview 262 or Freely 565
Visit Shots! now

This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement.

A new vaccine which has successfully cut down on coronavirus infections during trials will be rolled out by the NHS.

According to deputy chief medical officer Jonathan Van-Tam, the vaccine, created at Oxford University and manufactured by AstraZeneca, should be available just after Christmas, report the Sunday Times.

Hide Ad
Hide Ad

Mr Van-Tam told MPs last week stage three trials of the vaccine mean a mass rollout is on the horizon and thousands of NHS staff are to undergo training to administer the vaccine before the end of the year.

The government has changed the law this weekend to expand the number of health professionals able to inoculate the public. The regulations will enable pharmacists, dentists, midwives and paramedics to administer jabs.

The NHS hopes to roll out a COVID-19 vaccine for older people by the end of the yearThe NHS hopes to roll out a COVID-19 vaccine for older people by the end of the year
The NHS hopes to roll out a COVID-19 vaccine for older people by the end of the year

Mr Van-Tam said: “We aren't light years away from it. It isn't a totally unrealistic suggestion we could deploy a vaccine soon after Christmas. That would have a significant impact on hospital admissions and deaths.

Hide Ad
Hide Ad

Vaccines are being developed at a speed that, if successful, will save lives.”

The first vaccines will be given to the elderly and vulnerable and to vaccinate those most at risk will take several months. Most people will not be given the jab.

A health department official confirmed a “robust and comprehensive training programme” was being developed by the NHS to train more people to administer injections .

Hide Ad
Hide Ad

Health secretary Matt Hancock said: “These legal changes will help us into make sure we are ready to rollout a safe and effective COVID- 19 vaccine as soon as it has passed clinical trials and undergone rigorous checks by the regulator.”